PSA-IgM and iXip in the diagnosis and management of prostate cancer: clinical relevance and future potential. A review. Acta Biomed [Internet]. 2022 Jan. 19 [cited 2024 Jun. 30];92(6):e2021344. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/12058